STAKA Med Ltd. - Accounts to registrar (filleted) - small 18.2

STAKA Med Ltd. - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 11264101 Board of Directors 20.3.18 31.3.19 31.3.19 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure112641012018-03-19112641012019-03-31112641012018-03-202019-03-31112641012018-03-1911264101ns15:EnglandWales2018-03-202019-03-3111264101ns14:PoundSterling2018-03-202019-03-3111264101ns10:Director12018-03-202019-03-3111264101ns10:PrivateLimitedCompanyLtd2018-03-202019-03-3111264101ns10:SmallEntities2018-03-202019-03-3111264101ns10:AuditExempt-NoAccountantsReport2018-03-202019-03-3111264101ns10:SmallCompaniesRegimeForDirectorsReport2018-03-202019-03-3111264101ns10:SmallCompaniesRegimeForAccounts2018-03-202019-03-3111264101ns10:FullAccounts2018-03-202019-03-3111264101ns10:Director22018-03-202019-03-3111264101ns10:RegisteredOffice2018-03-202019-03-3111264101ns5:CurrentFinancialInstruments2019-03-3111264101ns5:ShareCapital2019-03-3111264101ns5:RetainedEarningsAccumulatedLosses2019-03-31


REGISTERED NUMBER: 11264101 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 20 MARCH 2018 TO 31 MARCH 2019

FOR

STAKA MED LTD.

STAKA MED LTD. (REGISTERED NUMBER: 11264101)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 20 MARCH 2018 TO 31 MARCH 2019










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


STAKA MED LTD.

COMPANY INFORMATION
FOR THE PERIOD 20 MARCH 2018 TO 31 MARCH 2019







DIRECTORS: Dr S Sharma
Mrs T Sharma





REGISTERED OFFICE: Riverside House
1-5 Como Street
Romford
RM7 7DN





REGISTERED NUMBER: 11264101 (England and Wales)





ACCOUNTANTS: Clemence Hoar Cummings
Chartered Accountants
Riverside House
1-5 Como Street
Romford
Essex
RM7 7DN

STAKA MED LTD. (REGISTERED NUMBER: 11264101)

BALANCE SHEET
31 MARCH 2019

Notes £   
CURRENT ASSETS
Cash at bank 63,581

CREDITORS
Amounts falling due within one year 4 19,146
NET CURRENT ASSETS 44,435
TOTAL ASSETS LESS CURRENT
LIABILITIES

44,435

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 44,335
SHAREHOLDERS' FUNDS 44,435

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2019.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of
the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company
as at the end of each financial year and of its profit or loss for each financial year in accordance with
the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 5 September 2019 and were signed
on its behalf by:





Dr S Sharma - Director


STAKA MED LTD. (REGISTERED NUMBER: 11264101)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 20 MARCH 2018 TO 31 MARCH 2019


1. STATUTORY INFORMATION

STAKA Med Ltd. is a private company, limited by shares , registered in England and Wales. The
company's registered number and registered office address can be found on the Company
Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income
Statement, except to the extent that it relates to items recognised in other comprehensive income
or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed
at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the period end and
that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is
probable that they will be recovered against the reversal of deferred tax liabilities or other future
taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 18,609
Other creditors 537
19,146